USFDA grants tentative approval to Lupin’s generic formulation for type 2 diabetes
USFDA grants tentative approval to Lupin’s generic formulation for type 2 diabetes Global pharma major Lupin Limited on Friday announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Dapagliflozin and Saxagliptin Tablets, 5 mg/5 mg and 10 mg/5 mg. According to the company’s press statement, the approval has been granted to market a generic equivalent of Qtern Tablets, 5 mg/5 mg and 10 mg/5 mg of AstraZeneca AB. This product will be manufactured at Lupin’s Pithampur facility in India. Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of USD 5 million in the U.S. (IQVIA MAT November 2023).
相关推荐
Charts signal strong support for these two stocks; recent market correction may have bottomed out
India’s Feb palm oil imports fall to 8-month low, say dealers
Buy these three shares for gains; Nifty bull run may have more legs, Bank Nifty support at 36200
IRFC stock surges to record high; check expert view on the stock and scope for profit booking
Investors need to focus on personal portfolio RoR instead of over optimising win rate
Meesho reports 14 crore customers, 80% orders from tier 2-plus markets in 2023
- 最近发表
- World Braille Day- Akasa Air’s initiative towards inclusive travel with Braille safety manuals and menus is winning hearts
- Markets Wrap – Wed, 1 Feb ‘23- Stocks end mixed, rupee gains; Global markets, Gold, Crude, Crypto updates
- Xiaomi announces HyperOS for India; roll out to begin with these devices this month
- IREDA shares set to debut on bourses; GMP looks favourable
- Year of concerts- From Taylor Swift’s Eras Tour To Madonna’s Celebration Tour
- Israel embassy blast- Delhi Police zeroes in on two men based on CCTV footage, security beefed up
- Year-end story- Steady rise in crop output fails to ease import dependence
- Mcap of 8 of top 10 valued firms soars Rs 1
- Windfall tax for domestic crude oil reimposed; duty on export of diesel slashed
- ITC, BHEL, Ashok Leyland, Larsen & Toubro among 108 stocks that hit 52-week highs; 18 touch 52-week lows
- 随机阅读
- IPL Auction 2024 witnessed 57% growth in total watch-time
- Israel budget plans for Gaza war to last through February, widening deficit
- Cement industry set to grow 3% in Q3, southern India set to see maximum growth
- Investment pledges worth Rs 6
- Is Nifty set to test the hurdle at 19850- See GIFT Nifty, FII data, F&O ban, crude, more before market opens_2
- Chandrayaan-3- ISRO launches its third Mission to Moon – See Stunning Photos
- Buy Cummins, MCX stocks for gains; Markets eye RBI MPC, state election outcome for directional cues this week
- Indian Rupee falls for 6th straight month in June; may remain patchy on capital outflow, dollar liquidity
- CBI issues notice to Jaihind Channel seeking details of DK Shivakumar’s investments
- Mcap of nine of top-10 most valued firms up Rs 1
- MCX Share Price- SEBI asks company to put launch of new platform on hold
- Central Banks gearing for a prolonged pause- Dollar slips, commodities gain on US Fed rate hike
- Is Bitcoin as bad as child prostitution- Charlie Munger’s scathing attack on cryptocurrency and its promoters
- Closing bell- Indices get a push in late trade, Nifty closes above 19600, Sensex above 65880; FMCG shines, banks face corrections
- IRCTC shares tank 5% as government announces stake sale via OFS
- Introducing Shivranjani Raje- Royal heiress of the world’s largest private residence with 347 rooms, host to Priyanka Chopra’s wedding
- ITC, Ashok Leyland, IndiGo, Adani Enterprises, IDBI Bank, sugar stocks in focus on weekly F&O expiry
- Is the IMF right on the rupee-
- Cipla soars on buzz of Blackstone stake buy
- CA Swift Investments sells 2
- 搜索
- 友情链接